Primaquine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01087 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 39 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | myiasis | KG + DL |
| 2 | wound myiasis | KG + DL |
| 3 | furuncular myiasis | KG + DL |
| 4 | creeping myiasis | KG + DL |
| 5 | toxoplasmosis | KG + DL |
| 6 | nocardiosis | KG + DL |
| 7 | malaria | KG + DL |
| 8 | pneumocystosis | KG + DL |
| 9 | tinea corporis | KG + DL |
| 10 | blastomycosis | KG + DL |
| 11 | infectious otitis media | KG + DL |
| 12 | enterobiasis | KG + DL |
| 13 | middle ear disease | KG + DL |
| 14 | chronic otitis media | KG + DL |
| 15 | otosalpingitis | KG + DL |
| 16 | non-suppurative otitis media | KG + DL |
| 17 | suppurative otitis media | KG + DL |
| 18 | endocardial fibroelastosis | KG + DL |
| 19 | allergic otitis media | KG + DL |
| 20 | middle ear cholesterol granuloma | KG + DL |
| 21 | endocarditis | KG + DL |
| 22 | Bacteroidaceae infectious disease | KG + DL |
| 23 | Plasmodium ovale malaria | KG + DL |
| 24 | paratyphoid fever | KG + DL |
| 25 | Cryptococcal meningitis | KG + DL |
| 26 | echinococcus granulosus infectious disease | KG + DL |
| 27 | anaerobic bacteria infectious disease | KG + DL |
| 28 | chronic ethmoidal sinusitis | KG + DL |
| 29 | conjunctivitis | KG + DL |
| 30 | paranasal sinus neoplasm (disease) | KG + DL |
| 31 | sinusitis | KG + DL |
| 32 | chronic rhinosinusitis | KG + DL |
| 33 | cutaneous candidiasis | KG + DL |
| 34 | nail infection | KG + DL |
| 35 | Trichinellosis | KG + DL |
| 36 | isosporiasis | KG + DL |
| 37 | cyclosporiasis | KG + DL |
| 38 | alveolar echinococcosis | KG + DL |
| 39 | geniculate herpes zoster | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.